What Is Cytek Biosciences, Inc. (CTKB) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Cytek Biosciences, Inc.'s intrinsic value is estimated at $2.38. Trading at its current price of $4.51, the valuation engine raises significant caution: 11 of 13 models flag downside risk, projecting an average implied return of -47.3%. Notably, FTNN sees the most upside at +8.9% (fair value: $4.91), while ML-RIV is the most conservative at -89.8% ($0.46). The spread between these extremes — +98.7% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About CTKB?
13 of 13 models are currently active for CTKB. Of these, 2 models suggest upside while 11 models suggest overvaluation. The Bayesian DCF estimates CTKB's intrinsic value at $1.42, implying -68.4% downside from the current price. See which stocks rank higher →
How Does CTKB Rank in Laboratory Analytical Instruments?
Among 21 Laboratory Analytical Instruments stocks, CTKB ranks #8 by Quality of Company score. CirclFi's QOC score of 7.1/10 evaluates 32 fundamental signals. A score of 7.1 indicates above-average quality.
Cytek Biosciences, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is CTKB a Value Trap?
CirclFi's Value Trap algorithm assigns CTKB a score of 33/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Cytek Biosciences, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Cytek Biosciences, Inc. earns a quality score of 7.1/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +98.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CTKB valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CTKB's 13 active models, average confidence is 33%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad